New patent expiration for Astrazeneca Pharms drug BRILINTA

Annual Drug Patent Expirations for BRILINTA Brilinta is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from two suppliers. There are six patents… The post New patent expiration for Astrazeneca Pharms drug BRILINTA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: